New drug combo shows promise for rare penile cancer
NCT ID NCT00210041
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a combination of two chemotherapy drugs, gemcitabine and cisplatin, can shrink tumors in people with advanced or metastatic penile cancer. Fifty adults with inoperable or spreading disease took part. The main goal was to see how many patients responded to the treatment, while also monitoring side effects and how long the benefit lasted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENITAL NEOPLASMS, MALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Grenoble
Grenoble, France
-
Centre Eugène Marquis
Rennes, France
-
Centre François Baclesse
Caen, France
-
Centre Léon Bérard
Lyon, France
-
Centre Médico-Chirurgical Foch
Suresnes, France
-
Centre Paul Papin
Angers, France
-
Institut Bergonie
Bordeaux, France
-
Institut Claudius Regaud
Toulouse, France
-
Institut Curie
Paris, France
-
Institut Paoli Calmette
Marseille, France
-
Institut Val d'aurelle
Montpellier, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.